Windtree Therapeutics Files 8-K on Financials
Ticker: WINTW · Form: 8-K · Filed: Apr 15, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Windtree Therapeutics filed an 8-K on April 15, 2025, for financial reporting.
AI Summary
Windtree Therapeutics, Inc. filed an 8-K on April 15, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational updates within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as a formal notification to investors and the public regarding the company's financial status and operational results, which can influence investment decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate operational or financial distress.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 15, 2025 (date) — Date of earliest event reported
- 2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976 (address) — Principal executive offices
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text for the 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not include specific financial figures or operational details within the excerpt.
What is the filing date for this 8-K report?
The filing date, or the date of the earliest event reported, is April 15, 2025.
What is the company's state of incorporation?
Windtree Therapeutics, Inc. is incorporated in Delaware.
What is the company's principal business address?
The company's principal business address is 2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976.
What SEC Act is this filing made under?
This filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).